Not Logged In     Login     Release 22.0, Sept. 2008   The Medical Algorithms Project Chapter : ch5. Transfusion Medicine Only the first few algorithm links in this page are active, as indicated by the icons. To have access to all the spreadsheets, please register (free) and login with your username. Estimation of Blood Loss and Prediction of Blood Transfusion Needs   Use of Hemoglobin to Guide Blood Replacement Therapy   Score of Larocque et al for Predicting Blood Transfusion in Knee or Hip Joint Arthroplasty   Estimating Blood Loss in the Bleeding Severity Index   Transfusion Planning Algorithm in Surgical Patients with Cancer of the Head and Neck   Identification of Total Joint Arthroplasties with Very Low Need for Perioperative Blood Transfusion and for Autologous Blood Collection   Preoperative Prediction of Red Blood Cell Transfusion in Surgical Patients   Standing Blood Order Equation of Nuttall et al   Equations of Bourke and Smith for Estimating Allowable Hemodilution   Predicting Need for Allogenic Blood Transfusion Following Surgery for Lung Cancer   Classes of the American College of Surgeons (ACS) for Acute Hemorrhage   Model of Karkouti et al for Predicting the Need for Blood Transfusion Associated with a First-Time Elective Coronary Bypass Graft Operation   Minimizing Allogeneic Blood Transfusion in Surgical Patients   Method of Grant and Reeve for Estimating Blood Loss in Severe Injury   Method of Cotterill for Estimating the Amount of Blood Loss in an Injured Limb   Model of Howe et al for Estimating Perioperative Hemorrhage in Orthopedic Surgery   Calculating the Blood Transfusion Requirement for a Patient with Chronic, Transfusion-Dependent Anemia   Criteria of Wu et al to Identify Cirrhotic Patients Who Do Not Need Blood Transfusion After Hepatic Tumor Resection   Model of Marec-Berard et al for Predicting Blood Transfusion After Chemotherapy in a Pediatric Patient with a Solid Tumor   Model of Ray-Coquard et al for Predicting Blood Transfusion in an Adult After Chemotherapy for a Solid Tumor   Method of Maull for Estimating Blood Loss with Severe Trauma   Prediction of Transfusion Requirements in a Trauma Patient Based on the Admission Base Deficit   Determining the Percent Red Blood Cell Volume Replaced Based on the Patient's Body Weight   Model of Lappas et al for Estimating Blood Use During Cardiac Bypass Surgery   Preoperative Predictors of Magovern et al for Transfusion After Coronary Artery Bypass Surgery   Preoperative Predictors of Berenholtz et al for Receiving a Blood Product During Spinal Surgery   The Trauma Associated Severe Hemorrhage (TASH) Score of Yucel et al for Predicting the Need for Massive Transfusion After Multiple Trauma   Risk Factors of Baker et al for Predicting the Need for Transfusion in a Trauma Patient   The Transfusion Risk Understanding Scoring Tool (TRUST) of Alghamdi et al for Predicting Transfusion in a Cardiac Surgery Patient   Model of Kling et al for Predicting Blood Transfusion in a Premature Infant in the ICU   Predictors of Blackmore et al for Major Hemorrhage in a Patient with a Pelvic Fracture   Transfusion Guidelines of West et al for the Trauma Patient   Estimating Blood Loss from Blood Loss into Field Dressings   Risk Index of McCluskey et al for Predicting Massive Blood Transfusion Associated with Liver Transplant Surgery   Model of Moore et al for Predicting the Probability of Massive Blood Transfusion in a Trauma Patient   Equation of Davies et al for Calculating the Required Red Blood Cell Transfusion Volume for a Child   Risk Factors of Brems et al for Blood Loss Associated with Orthotopic Liver Transplantation   Predictors of Nuttall et al for Blood Transfusion Associated with Spinal Fusion Surgery   Preoperative Predictors of Aderinto and Brenkel for Blood Transfusion After a Unilateral Total Hip Replacement   Adjusted Blood Requirement Index (ABRI) in a Patient with Portal Hypertension and Upper Gastrointestinal Bleeding   Risk Factors of Foss and Kehlet for Occult Blood Loss Following Surgery for a Hip Fracture   Risk Factors of Kinnaird et al for Major Blood Loss and for Transfusion Following a Percutaneous Coronary Intervention (PCI)   Transfusion Triggers of Moonen et al for a Patient Undergoing Primary Hip or Knee Arthroplasty   Preoperative Risk Factors of Dillon et al for Blood Transfusion in a Patient with a Hip Fracture   Predictors of Grosflam et al for Blood Loss During an Elective Total Hip Replacement   Predictors of Odumala et al for Excessive Blood Loss During Operative Repair of a Hip Fracture   Protocol of Wong et al for Reducing Allogeneic Blood Transfusion in a Patient Undergoing an Elective Total Hip Arthroplasty   Model of Moskowitz et al for Predicting the Probability of Allogeneic Blood Transfusion During Cardiac Surgery at a Hospital Practicing Blood Conservation   Risk Factors of Han et al for Blood Transfusion Following Nephrectomy for a Renal Cell Carcinoma   Risk Factors of Starr et al for Blood Transfusion in a Patient with Pelvic Fracture   Early Predictors of Schreiber et al for Massive Transfusion in a Combat Casualty   Risk Factors of Meert et al for Blood Transfusion in a Pediatric Patient Undergoing Spinal Fusion Surgery   Prediction Rule of Karkouti et al for Large Volume Blood Transfusion Associated with Cardiac Surgery Blood Component Collection and Processing   Donor Weight, Volume Collected and Anticoagulant Required for Blood Product Collection   Use of Unit Weight to Estimate Volume Collected During Blood Donation   Cleansing the Skin Prior to Blood Collection   Amount of Plasma to Remove from a Red Blood Cell Product to Achieve a Given Hematocrit   Risk Factors for Endogenous Particulates in Blood Components   Volume of Donor Blood Required to Deliver a Given Hemoglobin Transfusion Dose Red Cell Survival   Correction for Loss by Venous Sampling Exchange Transfusion   Partial Exchange Transfusion in Neonatal Polycythemia   Neonatal Exchange Transfusion for Hyperbilirubinemia   Exchange Transfusion in Children with Hepatic Failure Apheresis and Plasma Exchange   Removal of Material during Plasma Exchange   Serum Hydroxyethyl Starch (HES) Level   Plasmapheresis Protocol for the Treatment of the Guillain-Barre Syndrome   Scoring System of Bolan et al for Monitoring Citrate-Related Hypocalcemia During an Apheresis Procedure   Indications of Gordon et al for Performing Apheresis to Remove Low-Density Lipoprotein   Donor Criteria for Collection of 2 Red Blood Cell Products By Apheresis   Indications of Weinstein for Apheresis in a Patient with the Lambert-Eaton Myasthenic Syndrome (LEMS) Calculating the Probability of an Antibody's Presence   Fisher's Exact Method and the Probability of an Antibody's Presence   The Method of Harris and Hochman for Calculating the Probability of an Antibody's Presence Red Cell Antigenic Phenotypes   Phenotype Frequencies and Red Cell Compatibility   Calculation for Combined Phenotypes   Predicting the Rhesus Antigen Status of a Child from Parent's Phenotype   Probability that a D-positive Father is Heterozygous or Homozygous for the D Locus   Prediction of a Parent's ABO Phenotype and Genotype If the ABO Phenotypes of the Other Parent and a Single Child Are Known   Prediction of a Parent's ABO Phenotype If the ABO Phenotypes of the Other Parent and Several Children Are Known   Identification of Blood Group A Subgroups   Identification of Blood Group B Subgroups Leukoreduction of a Red Blood Cell Product   Efficiency of Leukoreduction Recovery of Red Blood Cells Following Special Processing   Estimating the Percent Red Cell Recovery Based on the Product Hematocrit   Equations of Lockwood et al for Calculating Red Blood Cell Recovery Associated with Freezing, Thawing and Washing a Blood Product Red Blood Cell Agglutination   Antibody Titration with Score   Grading the Agglutination Reaction in an Affinity Gel Microtube Red Blood Cell Product Transfusion   Transfusion of Blood Products When an ABO-Identical Donor Is Not Available   Problems Encountered When Adding Drugs to or Infusing Solutions With Red Blood Cell Products   Troubleshooting a Red Blood Cell Product That Is Infusing Too Slowly   Use of a Blood Warmer to Transfuse Blood Products   Pretransfusion Education of the Recipient with Informed Consent   Selection of Patients Suitable for Home Red Blood Cell Transfusion   Requirements for Home Transfusion of Blood Products Antiglobulin (Coombs) Testing   Deciding to Perform an Elution for the Workup of a Positive Direct Antiglobulin Test in the Newborn Infant Evaluating the Appropriate Use of Blood Products   Indications for Use of Irradiated Blood Products   Indications for Use of Granulocyte Pheresis Products   Indications of Nuttall et al for Red Blood Cell Transfusion   Criteria Map of Hume et al for Red Blood Cell Transfusion in Pediatric Patients   Criteria for Reissue of a Returned Red Blood Cell Product   Criteria for Neonatal Red Blood Cell Transfusion   Patients at Risk for Cerebral or Myocardial Ischemia During Volume Depletion   Signs and Symptoms Requiring Red Blood Cell Transfusion in a Normovolemic Patient   Algorithm from the American College of Physicians (ACP) for Red Blood Cell Transfusion in a Patient with Transient Anemia After Acute Blood Loss   Algorithm from the American College of Physicians (ACP) for Red Blood Cell Transfusion in a Patient with Persistent Anemia Transfusion Reactions and Complications   Febrile Nonhemolytic Transfusion Reactions   Dilutional Coagulopathy Following Massive Transfusion   Transfusion-Transmitted Cytomegalovirus (CMV) Infection   Transfusion-Related Acute Lung Injury (TRALI)   Pseudo-Hemolytic Transfusion Reaction After Intravenous Iron Dextran Infusion   Evaluation of a Patient After a First Episode of an Anaphylactic Transfusion Reaction   Citrate Toxicity   Heat Loss After Infusion of Refrigerated Blood   Indications for the Use of Diphenhydramine (Benadryl) in Allergic Transfusion Reactions   Hyperhemolytic Transfusion Reaction in Patients with Sickle Cell Disease   Posttransfusion Purpura   Prevention of Bacterial Contamination in Blood Products   Air Embolism   Aseptic Meningitis After Infusion of Intravenous Immunoglobulin   Hyperviscosity After Infusion of Intravenous Immunoglobulin   Acute Renal Failure After Infusion of Intravenous Immunoglobulin   Cerebral Infarction After Infusion of Intravenous Immunoglobulin   Hemolysis After Infusion of Intravenous Immunoglobulin   Anaphylactoid Reactions in a Patient Receiving an Angiotensin Converting Enzyme (ACE) Inhibitor   Allergic Reaction Following Infusion of Blood Products Through Intravenous Infusion Equipment Sterilized in Ethylene Oxide Gas   Conditions That May Mask a Hemolytic Transfusion Reaction   Pseudo-Hemolytic Transfusion Reaction Associated with In Vitro Hemolysis   Clinical Features of an Acute Immune Hemolytic Transfusion Reaction   Evaluation of a Donor Whose Blood Product Has Grown Bacteria on Culture   Determining if a Blood Product with a Positive Bacterial Culture May Have Been Contaminated at the Time of Collection or During Processing   Graft versus Host Disease (GVHD)   Circulatory Overload Following Blood Product Transfusion   Neonatal Hyperkalemia Following Blood Transfusion   Effects of Dimethylsulfoxide (DMSO) Associated with Infusion of Peripheral Blood Progenitor Cells (PBPC)   Clinical Features of the Acute Pain Transfusion Reaction   Hemolytic Transfusion Reaction Associated with an HLA Alloantibody   Risk Factors for Mechanical Hemolysis of Red Cells During Blood Infusion   Protocol of Kohan et al for High Dose Intravenous Immunoglobulin (IVIG) to Prevent Hemolysis Following a Non-ABO Incompatible Blood Transfusion   Acute Hemolysis and Disseminated Intravascular Coagulation (DIC) Following Administration of RhoGAM (Rh Immune Globulin) to an Rh-Positive Patient with Immune Thrombocytopenic Purpura (ITP)   Parvovirus B19 Transmission by Blood Products   Acute Infusion Reaction Folllowing Infusion of Intravenous Immunoglobulin (IVIG)   Pseudo-Transfusion Reaction Associated with a Change in Vital Signs   Pseudo-Hemolytic Transfusion Reaction Associated with Clostridium Sepsis   Risk Factors for Developing an Infection After a Blood Transfusion Overseas in a Developing Country Autologous Blood Transfusion   Contraindications to Autologous Blood Donation Immunoglobulin Infusion Therapy   Calculating the Immunoglobulin Intravenous Infusion Rate Platelet Replacement Therapy   Calculation of Platelet Replacement Needs   The Corrected Count Increment (CCI) and the Increment in Platelet Count after Platelet Transfusion   Criteria of Petz et al for Refractoriness to Platelet Transfusion   The Maximum Platelet Count Increment (MPI) and Percentage Platelet Recovery (PPR)   Calculating the Corrected Count Increment (CCI) from the Percentage Platelet Recovery (PPR)   Prediction of the Platelet Count Increment (CI) After Platelet Transfusion Using the Equation of Bishop et al   Administration of Rh Immune Globulin (RhoGAM, RhIG) to Prevent Alloimmunization After Administering Platelets from an Rh-Positive Donor to an Rh-Negative Patient   Criteria of Rebulla et al for Administering Prophylactic Platelet Transfusions in a Patient with Acute Myeloid Leukemia Transfusion Therapy in Patients with Sickle Cell Disease   Indications for Transfusion in Patients with Sickle Cell Disease   Simple Transfusion in Sickle Cell Disease and the Effect on Hemoglobin S Concentration   Calculating Exchange Volumes for Exchange Transfusions in a Patient with Sickle Cell Disease   Indications and Contraindications of Walters et al for Bone Marrow Transplantation in a Pediatric Patient with Sickle Cell Disease Blood Recovery (Salvage) and Reinfusion   Indications for Blood Recovery and Autotransfusion in Surgical Patients   Suctioned Contaminants That May Limit the Usability of Recovered Blood for Autotransfusion Hematopoietic Progenitor Cells (HPC)   Product and Patient Handling Before Infusing an Allogeneic HPC Unit from an ABO-Incompatible Donor   Component Selection for Transfusion Therapy Following Transplantation with Hematopoietic Progenitor Cells from an ABO or D-Incompatible Donor Pretransfusion Testing   The Computer Crossmatch   Troubleshooting Positive Pretransfusion Testing Problems in Red Blood Cell Testing   Identification of Polyagglutinable Antigen Type Using Lectins   Evaluation of a Patient with Polyagglutinable Red Blood Cells Surgical Management of a Jehovah's Witness Without Blood Transfusion   Strategies of van Son et al for Performing Heart Surgery with Cardiopulmonary Bypass in an Infant Without Blood Transfusion Use of Blood Products in Cardiopulmonary Bypass Surgery   Volume of Blood Required to Prime the Extracorporeal Circuit for Cardiopulmonary Bypass Intrauterine Fetal Transfusion   Equation of Nicolaides et al for Calculating the Volume of Donor Blood to Transfuse in a Fetus with Erythroblastosis Fetalis   Equation of MacGregor et al for Predicting the Fetal Hematocrit After an Intravascular Intrauterine Red Blood Cell Transfusion   Equation of Hoogeveen et al for Determining the Volume of Donor Blood for an Intrauterine Blood Transfusion   Equation of Moise for Calculating the Volume of a Platelet Concentrate to Infuse Into a Fetus with Thrombocytopenia   Calculating the Volume of Blood Needed for an Intraperitoneal Transfusion Tissue Banking and Organ Handling   Data to Record for Every Allograft Therapeutic Phlebotomy   Identification of a Patient Who May Require Precautions During Therapeutic Phlebotomy   Indications for Therapeutic Phlebotomy   Checklist for Proper Documentation of Therapeutic Phlebotomy Evaluation of the Blood Donor   Blood Donor Reaction Inventory of Meade et al   Models of Newman and Roth for Predicting the Probability of an Adverse Reaction in a Blood Donor   Deferral of Donors Taking Potentially Teratogenic Drugs Bone Marrow Transplantation   Complications of Donor Bone Marrow Harvesting for Transplant Stem Cell Transplantation   Peripheral Blood Progenitor Cell (PBPC) Collection Based on the Study of Ford et al   Adequacy in Mobilization of CD34+ Peripheral Blood Progenitor Cell (PBPC)   Pretransplantation Assessment of Mortality (PAM) Score for a Patient Undergoing an Allogeneic Stem Cell Transplantation Managing the Red Blood Cell Inventory   Using the Average Weekly Use to Determine a Baseline Red Blood Cell Inventory   Determining Whether an Untransfused Red Blood Cell Unit Can Be Placed Back Into Inventory and Reissued for Transfusion Transfusion Therapy in a Patient with an Autoantibody   Algorithm of Shirey et al for Prophylactic Antigen-Matched Donor Blood for Transfusing a Patient with a Warm Autoantibody Artificial Blood and Blood Substitutes   Evaluating Hemoglobin Concentrations in a Patient Receiving Polymerized Hemoglobin   TOP

Copyright Institute of Algorithmic Medicine Under License to Medal.Org, Ltd